Lexaria Bioscience Corp.
Pharmaceutical Preparations · KELOWNA
High confidence (85%)
Updated Oct 3, 2026, 12:03 AM
What is happening
Derived by rule set status-rules-2026.09.7
The company stopped being publicly listed. A listing ends on the close of a merger as surely as it ends in failure, and the filing does not say which happened here.
Latest material event: Lexaria Bioscience Corp. received a delisting notice from its exchange (Aug 4, 2026)
Timeline
Every material event, newest first. History is never overwritten.
Lexaria Bioscience Corp. received a delisting notice from its exchange
Aug 4, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy Continued Listing Rule or Standard; Transfer of Listing Nasdaq Delisting Notification On August 4, 2026 Lexaria Bioscience Corp. (the Company ) received a notification (the Notification ) from the Nasdaq Capital Market ( Nasdaq ) that, due to its failure to regain compliance with Nasdaq Listing Rule 5550(a)(2), being the requirement to maintain a $1.00 minimum bid price, (the Bid Price Requirement ) within the 180 day compliance period provided under Nasdaq Listing Rule 5810(c)(3)(A), it would be delisted from the Nasdaq, subject to any reque…”
Lexaria Bioscience Corp. received a delisting notice from its exchange
Feb 4, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy Continued Listing Rule or Standard; Transfer of Listing Nasdaq Bid Price Deficiency Notice On February 4, 2026, Lexaria Bioscience Corp. (the Company ) received a letter (the Bid Price Deficiency Notice ) from the listing qualifications department staff of The Nasdaq Stock Market ( Nasdaq ) indicating that the Company is not in compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market (the Bid Price Requirement ). The Bid Price Deficiency Notice has n…”
Lexaria Bioscience Corp. was delisted from its exchange
Jan 14, 2026
Delisting effective
- SEC EDGAR — “X0203 0001354457 Nasdaq Stock Market LLC 0001348362 Lexaria Bioscience Corp. 001-39874 100 - 740 McCurdy Road Kelowna/ British Columbia IL ILLINOIS V1X 2P7 250-765-6424 (203) warrant 17 CFR 240.12d2-2(a)(2) Tara Petta AVP 2026-01-13”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- Listing
- SEC lists the ticker LEXX on Nasdaq.
- SEC CIK
- 0001348362
- Website
- —
- —
- Headquarters
- KELOWNA
- Also known as
- Lexaria Corp.
- Legal entities
- Lexaria Bioscience Corp.
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
Lexaria Bioscience Corp. — Pharmaceutical Preparations (SIC 2834) — KELOWNA, British Columbia, Canada
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy Continued Listing Rule or Standard; Transfer of Listing Nasdaq Bid Price Deficiency Notice On February 4, 2026, Lexaria Bioscience Corp. (the Company ) received a letter (the Bid Price Deficiency Notice ) from the listing qualifications department staff of The Nasdaq Stock Market ( Nasdaq ) indicating that the Company is not in compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market (the Bid Price Requirement ). The Bid Price Deficiency Notice has n…
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
X0203 0001354457 Nasdaq Stock Market LLC 0001348362 Lexaria Bioscience Corp. 001-39874 100 - 740 McCurdy Road Kelowna/ British Columbia IL ILLINOIS V1X 2P7 250-765-6424 (203) warrant 17 CFR 240.12d2-2(a)(2) Tara Petta AVP 2026-01-13
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy Continued Listing Rule or Standard; Transfer of Listing Nasdaq Delisting Notification On August 4, 2026 Lexaria Bioscience Corp. (the Company ) received a notification (the Notification ) from the Nasdaq Capital Market ( Nasdaq ) that, due to its failure to regain compliance with Nasdaq Listing Rule 5550(a)(2), being the requirement to maintain a $1.00 minimum bid price, (the Bid Price Requirement ) within the 180 day compliance period provided under Nasdaq Listing Rule 5810(c)(3)(A), it would be delisted from the Nasdaq, subject to any reque…
View source record
Status history
Every derived status, with the rule that produced it.
- DISTRESS_SIGNAL → NO_LONGER_LISTEDPUBLIC_LISTING_ENDED · Sep 18, 2026, 01:29 AM
The company stopped being publicly listed. A listing ends on the close of a merger as surely as it ends in failure, and the filing does not say which happened here.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:15 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:33 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 13, 2026, 12:14 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:32 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.